Several studies have investigated the mechanisms underlying naringenin-mediated anti-cancer effects and have identified a variety of mechanisms (Table 2), including immunomodulation, NFκB-signaling, ROS-mediated induction of apoptosis, PI3K/Akt pathway, and TGFβ-mediated signaling pathways. This evidence concerns the gene AKT1 and cancer.